Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.498
https://www.valueinhealthjournal.com/article/S1098-3015(13)02403-0/fulltext
Section Title : Disease-Specific Studies
Section Order : 475
First Page : A409
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02403-0&doi=10.1016/j.jval.2013.08.498
HEOR Topics :
Tags :
Regions :